Cargando…
Inducing T cell dysfunction by chronic stimulation of CAR-engineered T cells targeting cancer cells in suspension cultures
Several pre-clinical models reveal that chronic chimeric antigen receptor (CAR) stimulation drives a dysfunctional state that mimics in vivo failure. In this protocol, we describe steps to induce T cell dysfunction by persistent and long-term stimulation of CAR-engineered T cells using antigen-expre...
Autores principales: | Selli, Mehmet Emrah, Landmann, Jack H., Arveseth, Corvin, Singh, Nathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826863/ https://www.ncbi.nlm.nih.gov/pubmed/36607811 http://dx.doi.org/10.1016/j.xpro.2022.101954 |
Ejemplares similares
-
Antigen glycosylation regulates efficacy of CAR T cells targeting CD19
por: Heard, Amanda, et al.
Publicado: (2022) -
Protocol to engineer apical-out airway organoids using suspension culture of human airway basal stem cell aggregates
por: Wijesekara, Piyumi, et al.
Publicado: (2023) -
Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation
por: Larcombe-Young, Daniel, et al.
Publicado: (2022) -
Generation of Human iMelanocytes from Induced Pluripotent Stem Cells through a Suspension Culture System
por: Liu, Li-Ping, et al.
Publicado: (2020) -
In vitro evaluation of CAR-T cells in patient-derived glioblastoma models
por: Brakel, Benjamin A., et al.
Publicado: (2021)